SecBot SecBot
6-K ·Filed Apr 16, 2026

SNNUF

SMITH & NEPHEW PLC
NEUTRAL
Impact 3/10
Horizonmonths Processed6mo ago SEC0001654954-26-003575
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading implications. Monitor for future insider transaction patterns, especially if share sales follow vesting. This is a routine disclosure under UK MAR, not a strategic or financial update.

DirectionNeutral
Confidencehigh
Horizonmonths
Final — all horizons settled through T+60d ⚠ clustered
SNNUF ▼ -15.76% at T+60d
NEUTRAL call -15.76% · α vs SPY -22.80% · entry $15.55 → $13.10
Entry = T+0 close
Apr 16, 2026
via day close
T+1d
0.00%
call 0.00% · α -1.21%
$15.55
settled 6mo ago
T+5d
+4.05%
call +4.05% · α +3.07%
$16.18
settled 6mo ago
T+20d
-3.86%
call -3.86% · α -9.67%
$14.95
settled 6mo ago
T+60d
-15.76%
call -15.76% · α -22.80%
$13.10
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Smith & Nephew plc disclosed the grant of 50 ordinary shares to each of 12 senior executives, including the CEO and CFO, under the RISE Share Plan on April 15, 2026. These awards are part of ongoing executive compensation and not tied to a material financial event.

Key Facts

  • 12 PDMRs (Persons Discharging Managerial Responsibilities) each received 50 ordinary shares in Smith & Nephew plc.
  • Awards were granted under the RISE Share Plan, a sub-plan of the Smith & Nephew plc Restricted Share Plan 2024.
  • No monetary price was paid (Price: 'Nil'), consistent with a compensation award.
  • Transaction date: April 15, 2026; filing date: April 16, 2026.
  • Grant occurred outside a trading venue, indicating a direct issuance rather than open market purchase.

Financial Impact

Minimal. Total shares awarded: 600 (12 executives × 50 shares). No disclosed cash value or dilution impact.

dilutionexecutive compensation

Risk Factors

  • Minimal dilution from small share issuance, though not quantified.
  • Perception risk if future performance does not justify executive compensation.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003575
Document: 0001654954-26-003575-index-headers.html0001654954-26-003575
Document: 0001654954-26-003575-index.html0001654954-26-003575
Document: 0001654954-26-003575.txt0001654954-26-003575
10 reports for SNNUF
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for SNNUF — sortable, filterable
TypeNow
Jun 4, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$14.91 $15.48▲ +3.82%▲ +1.94%$13.22 (−11.33%)
Jun 3, 2026
20w ago
6-K
NEUTRAL ★ 1/10
$14.91 $15.48▲ +3.82%▲ +1.32%$13.22 (−11.33%)
Jun 3, 2026
20w ago
6-K
NEUTRAL ★ 2/10
$14.91 $15.48▲ +3.82%▲ +1.32%$13.22 (−11.33%)
May 20, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$14.91 $15.48▲ +3.82%▼ −1.18%$13.22 (−11.33%)
May 14, 2026
23w ago
6-K
BULLISH ★ 7/10
$14.95 $15.48▲ +3.55%▼ −0.04%$13.22 (−11.57%)
May 12, 2026
23w ago
6-K
NEUTRAL ★ 1/10
$14.95 $15.48▲ +3.55%▼ −0.84%$13.22 (−11.57%)
May 1, 2026
25w ago
6-K
NEUTRAL ★ 1/10
$15.55 $15.75▲ +1.29%▼ −1.78%$13.22 (−14.98%)
Apr 16, 2026
27w ago
6-K
NEUTRAL ★ 3/10
$15.55 $13.10▼ −15.76%▼ −22.80%$13.22 (−14.98%)
Apr 15, 2026
27w ago
6-K
NEUTRAL ★ 2/10
$15.70 $13.10▼ −16.56%▼ −24.70%$13.22 (−15.80%)
Apr 1, 2026
29w ago
6-K
NEUTRAL ★ 2/10
$16.05 $13.10▼ −18.38%▼ −31.76%$13.22 (−17.63%)
Showing 10 of 10

US Market Status

Market Closed — Opens in 3h 11m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026